ScubaTx expands to Manchester following a £1.5m funding boost to innovate in organ transplant technology.
The life sciences firm aims to leverage regional expertise, enhancing its operational and research capabilities to transform transplant practices.
ScubaTx Expands to Manchester
ScubaTx, a pioneering force in life sciences, has strategically established a new base in Manchester. The move follows a successful £1.5 million funding round, which was spearheaded by the Praetura Ventures-managed GMC Life Sciences Fund. Located at the Manchester Science Park, the firm aims to leverage the region’s rich life sciences resources to advance organ transplant technology.
Innovative Organ Preservation Technology
Founded by Dr William Scott, ScubaTx is at the forefront of organ preservation innovation. The company employs ‘persufflation’ to extend the viability of donated organs. This method involves cooling and oxygenating organs using humidified gas, a technique that has a robust scientific basis and holds promise for improving transplant outcomes.
Strategic Growth and Workforce Expansion
Following its recent growth, ScubaTx has expanded its team to 12 members at its new office. Six new hires will focus on operational capabilities, quality assurance, and regulatory affairs, among other areas. The Manchester office not only signifies a physical expansion for the company but also represents a commitment to enhancing its capabilities and fostering innovation.
Partnerships and Future Prospects
David Campbell, ScubaTx’s CEO, emphasises the significance of the new office as a milestone in the company’s journey. The Manchester base is expected to facilitate greater engagement with commercial partners, particularly in the US, where interest is growing. The firm’s strategic location is pivotal for its plans to revolutionise organ transplantation globally, aligning with its mission to improve health outcomes.
Funding and Innovation Support
The GMC Life Sciences Fund, a collaborative entity, plays a crucial role in ScubaTx’s expansion. Managed by Praetura Ventures, it supports life sciences advancements in the North West. This funding, along with investments from Innovate UK and other partners, enables ScubaTx to drive its innovative projects forward. The backing highlights confidence in the company’s potential to transform the transplantation field.
Impact on Organ Transplantation Practice
The advancements made by ScubaTx could lead to revolutionary changes in organ transplantation. The persufflation technique has the potential to increase the number of organs that successfully reach recipients. This innovation promises to enhance the quality of life for transplant patients globally, addressing the growing demand for viable organs.
Manchester’s Role in Life Sciences
Manchester has emerged as a hub for life sciences innovation. The expertise available in the region aligns with ScubaTx’s objectives, providing a supportive environment for the company’s ambitious plans. The city’s collaborative ecosystem and access to resources are instrumental in advancing ScubaTx’s mission to improve organ transplant technology.
Looking Forward
With the new office in Manchester, ScubaTx enters a promising phase of growth and innovation. The strategic expansion marks a critical juncture in its efforts to revolutionise organ transplantation processes, supported by expert local talent and strategic partnerships.
ScubaTx’s move to Manchester marks a pivotal step in its innovation journey, supported by strategic funding and regional expertise.
The company’s advancements in organ transplantation technology promise to improve patient outcomes and address global transplant needs.
